The primary motivation for conducting short-term tests for environmental mutagens and carcinogens has been to predict mutagens and/or carcinogens and to assess any associated risks. Organ-speciˆc in vivo short-term tests in rodents are valuable because chemical carcinogenesis is generally organ-speciˆc. I have attempted to develop various organ-speciˆc in vivo short-term tests mainly in rodent liver and stomach. Recently, our collaborative study group, Toxicogenomics/Japanese Environmental Mutagen Society･Mammalian Mutagenicity Study Group (JEMS･ MMS), attempted to use gene expression proˆling in in vivo short-term tests, conducted DNA microarrays to extract candidate marker genes, and later shifted to quantitative real-time PCR (qPCR) to proˆle the expression of selected genes. We successfully discriminated 8 genotoxic hepatocarcinogens from 4 non-genotoxic hepatocarcinogens by statistical analysis using principal component analysis (PCA) based on the gene expression proˆles for 12 genes (Aen, Bax, Btg2, Ccnf, Ccng1, Cdkn1a, Gdf15, Lrp1, Mbd1, Phlda3, Plk2, and Tubb2c) in mouse liver at 4 and 48 h following a single intraperitoneal administration of chemicals as determined by qPCR. More recently, we successfully performed a similar study in rat liver. Previously, my collaborators and I developed various organspeciˆc in vivo short-term test methods, including UDS (unscheduled DNA synthesis); RDS (replicative DNA synthesis) using a liquid scintillation counter in rat glandular stomach, forestomach, colon, and liver and hairless mouse epidermis; DNA single-strand scission (DSS); and ornithine decarboxylase assay (ODC) in rat glandular stomach on 62 compounds. Developing short-term tests that are helpful for the risk assessment of human mutagens and carcinogens would contribute to the development of ideal prediction methods.
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Introduction
Mahadevan et al. suggested that``driven by regulatory concerns, the primary reason for conducting in vitro and in vivo genotoxicity analyses has been to try to predict which molecules are likely to be rodent and/or human carcinogens'' (1). Additionally, Bucher and Portier suggested that``as our collective understanding of carcinogenesis advances, toxicologists and regulatory scientists will at some point begin to rely on mechanismbased biological observations rather than the 2-year rodent bioassay to predict human cancer hazards'' (2). According to Waters et al., although the number of presumed non-genotoxic rodent carcinogens has dramatically increased over the past 2 decades, ¿90z of the known, probable and possible human carcinogens classiˆed by the International Agency for Research on Cancer are detected in conventional short-term tests for genotoxicity and can induce tumors at multiple sites in rodents (3) . New and innovative assays to characterize the key steps in toxicity pathways, including genotoxic and nongenotoxic mechanisms for carcinogenesis, are waiting to be developed.
In the 1980s, my collaborators and I began investigating organ-speciˆc in vivo short-term tests for environmental mutagens and carcinogens using simple methods to detect DNA damage, DNA repair, and cell proliferation, including UDS (unscheduled DNA synthesis), DSS (DNA single-strand scission), RDS (replicative DNA synthesis), and ODC (ornithine decarboxylase assay), to identify any hazards. In the 2000s, our collaborative study group, Toxicogenomics/Japanese Environmental Mutagen Society･Mammalian Mutagenicity Study Group (JEMS･MMS), focused on gene expression proˆling to investigate the mode of action of particular chemicals on gene expression.
Here, I review our studies on gene expression proˆl-ing in rodent liver induced by hepatocarcinogens and various organ-speciˆc in vivo short-term tests in glandular stomach and additional organs.
An Attempt at Using Gene Expression Proˆling for an Organ-speciˆc In Vivo Short-term Test Discrimination of genotoxic and non-genotoxic mouse hepatocarcinogens as analyzed by qPCR (quantitative real time polymerase chain reaction) and PCA (principal component analysis): It is hypothesized that genotoxic and non-genotoxic carcinogens induce distinct gene expression proˆles, which consequently may be used for a mechanism-based classiˆcation of unknown compounds as either genotoxic or non-genotoxic carcinogens (4) . DNA microarray analysis is a powerful technique used for characterizing gene expression on a genome scale (5), although issues of reliability, reproducibility, and the correlation of data produced across diŠerent DNA microarrays are still being addressed (6) . qPCR is generally considered the``goldstandard'' assay for measuring gene expression and is often used to conˆrm DNA microarray data (7) . qPCR is the most sensitive technique used for the detection and quantiˆcation of mRNA targets (8). Mahadevan et al. suggested that it is possible to screen for carcinogenicity and discern the potential mode of action (MOA) of a chemical based on analysis of gene expression using toxicogenomics methods, with the potential for screening putative MOA by qPCR (1) . However, the published studies using DNA microarray or qPCR on in vivo rodent livers with hepatocarcinogens are limited.
Toxicogenomics/JEMS･MMS attempted to use gene expression proˆling as an in vivo short-term test to identify a mechanism-based classiˆcation of unknown compounds. In addition, we studied hepatocarcinogens, as the liver is the major target organ for experimental chemical carcinogenesis in rodents. We recently successfully discriminated 8 mouse genotoxic hepatocarcinogens from 4 non-genotoxic hepatocarcinogens through selected gene expression proˆling in mouse liver based on qPCR and statistical analysis using PCA (9) . The total RNA from an individual liver from groups of 5 male 9-week-old B6C3F1 mice was reverse-transcribed to cDNA, and the amount of each gene was quantiˆed by qPCR at 4 and 48 h following a single intraperitoneal administration of chemicals. It was speculated that DNA damage would occur 4 h post-hepatocarcinogen administration in the liver, as determined by in vivo/in vitro UDS assay (10) (11) (12) and DNA adduct analysis (13) , and that the 48-h time point would represent the period of RDS testing (10) (11) (12) 14) . Intraperitoneal injection or oral administration was usually used in genotoxicity tests in rodent liver (15, 16) . We quantiˆed 35 genes selected from our previous DNA microarray and qPCR studies (17, 18) Finally, we successfully discriminated the genotoxic from the non-genotoxic hepatocarcinogens by statistical analysis using PCA on the gene expression proˆles. PCA on the gene expression proˆle of 7 genes (Btg2, Ccnf, Ccng1, Lrp1, Mbd1, Phlda3, and Tubb2c) at 4 h ( Fig. 1-A ) and 12 genes (Aen, Bax, Btg2, Ccnf, Ccng1, Cdkn1a, Gdf15, Lrp1, Mbd1, Phlda3, Plk2, and Tubb2c) at 48 h ( Fig. 1-B ) yielded an optimal separation between the genotoxic and the non-genotoxic hepatocarcinogens and successfully discriminated the genotoxic from the non-genotoxic hepatocarcinogens by theˆrst principal component (PC1). The changes appeared to be greater at 4 h than at 48 h. Therefore, we used the 4-h time point for theˆrst experiment. Statistical analysis by PCA involves a mathematical procedure that transforms a number of possibly correlated variables into a smaller number of uncorrelated variables called``principal components''. Theˆrst principal component (PC1) accounts for as much of the variability in the data as possible, and each succeeding component accounts for as much of the remaining variability as possible. PCA was performed using the PCA program in GeneSpringGX11.0.1.
Seven major biological processes were extracted by gene ontology analysis (http://www.geneontology. org/): apoptosis, the cell cycle, cell proliferation, DNA damage, DNA repair, oncogenesis, and tumor suppression. The major, biologically relevant gene pathway identiˆed through this analysis was the DNA damage response pathway, which results from signal transduction through a p53-class mediator leading to the induc- Fig. 2 . The gene networks and pathways of 19 mouse genes as determined by qPCR. The network was combined from the results of IPA, GeneSpring software and references from PubMed. The 9 genes indicated by``*'' mark genes that signiˆcantly contributed to the discrimination of the genotoxic from the non-genotoxic mouse hepatocarcinogens by PCA. (9) 33 Organ-speciˆc In Vivo Short-term Tests tion of apoptosis. Eight genes (Aen, Bax, Btg2, Ccng1, Cdkn1a, Gdf15, Phlda3, and Plk2) that are directly associated with Trp53 contributed to the PCA (Fig. 2) . The currentˆndings demonstrate a successful discrimination between genotoxic and non-genotoxic hepatocarcinogens, using qPCR and PCA, on 12 genes associated with a Trp53-mediated signaling pathway for DNA damage response at 4 and 48 h after a single administration of chemicals. Regarding the expression of Trp53 itself, a statistically signiˆcant increase (less than twofold) with only the NNK injection at the 48-h time point was observed, although the basal expression of Trp53 in the control animal may already have been su‹cient for DNA damage under the present experimental conditions (9) . Little is known about the acute expression changes of Trp53 in rodent liver after exposure to hepatocarcinogens; only a few reports have suggested the activation of a Trp53-mediated signaling pathway following the administration of hepatocarcinogens (19) .
Seven genotoxic hepatocarcinogens were positive using the standard Ames test [2AAF (20) , DAB (21), DAT (22) , DIPN (23), NNK (24), NNM (22) , and QN (25) ]. URE was negative using the standard Ames test but positive under special conditions (26) . Seven genotoxic hepatocarcinogens were positive in the liver in transgenic mouse studies [2AAF (27) ; DAT (28); DIPN: Takayoshi Suzuki, unpublished data; NNK (29); NNM: Takayoshi Suzuki, unpublished data; QN (30) ; and URE (31)]. DAB was positive in the mouse liver using the Comet assay (32) . Four non-genotoxic hepatocarcinogens were negative using both the Ames test [DCB (33) , DDT (34), DEHP (35) and FUR (36) ] and in vivo genotoxicity tests [DCB (37) , DDT (38) , DEHP (39) , and FUR (40)].
In future studies, two recently described, advanced techniques, high-density real-time PCR (41) and ion torrent semiconductor chip based sequencing (42) , would increase the e‹ciency of examining gene expression proles; however, we have performed a large number of qPCR experiments manually. In the present study, we simply discriminated genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens. However, mechanism-based tests to predict human non-genotoxic carcinogens will be required in a diŠerent way; nongenotoxic carcinogens are designated as substances that induce cancer through the indirect stimulation of hyperplastic responses, without altering DNA, chromosome number, or structure. A wide variety of mechanisms of cancer induction, including receptor-mediated endocrine modulation, non-receptor mediated endocrine modulation, tumor promotion, inducers of tissuespeciˆc toxicity and in‰ammatory responses, immunosuppressants, and gap junction intercellular communication inhibitors, are proposed for non-genotoxic carcinogens (43) . Dose-dependent alterations in gene expression in mouse liver by diethylnitrosamine (DEN) and ethylnitrosourea (ENU) as determined by qPCR: Previously, we examined the dose-dependency of changes in gene expression for 51 genes in mouse liver treated with 4 doses of 2 N-nitroso genotoxic hepatocarcinogens, DEN and ENU, by qPCR (18) . Fifty-one genes were selected from our previous DNA microarray studies (17) . DEN (3, 9, 27, and 80 mg/kg bw, 1/40-1/2 of 50z lethal dose (LD50)) or ENU (6, 17, 50, and 150 mg/kg bw, 1/80-1/3 of LD50) was injected intraperitoneally into groups of 5 male 9-week-old B6C3F 1 mice, and the livers were dissected after 4 h and 28 days. qPCR results were analyzed by hierarchical and k-means clustering and Ingenuity Pathways Analysis (IPA, http://www.ingenuity.com/). The most characteristic result was a similar dose-dependency of gene expression changes with DEN and ENU. Twenty-one genes exhibited a deˆnite dose-dependent increase in expression at 4 h for both carcinogens (Aen, Bax, Btg2, Ccng1, Cdkn1a, Cyp4a10, Cyp21a1, Fos, Gadd45b, Gdf15, Hmox1, Hspb1, Jun, Mbd1, Mdm2, Myc, Net1, Plk2, Ppp1r3c, Rcan1, and Tubb2c), although the increase in gene expression due to ENU was generally weaker than that due to DEN. Only Gdf15 showed a dose-dependent increase in expression at 28 days for both carcinogens. IPA showed that these changes were associated with cancer, cell cycle arrest, DNA replication, recombination and repair and cell death and were observed not only 4 h but also, for some, 28 days after administration (18) .
DiŠerential gene expression between genotoxic and non-genotoxic mouse hepatocarcinogens as determined by DNA microarray: Before we shifted to the qPCR method, we conducted preliminary studies to assess diŠerential gene expression using DNA microarrays following the application of 13 [ethanol] . Dozens of candidate genes were extracted to discriminate the genotoxic hepatocarcinogens from the non-genotoxic hepatocarcinogens, and the results were reported in part (17) and registered in the NCBI Gene Expression Omnibus (GEO) database (GEO accession GSE33248 by Takayoshi Suzuki). We examined changes in gene expression by DNA microarray at 4 and 20 h and 14 and 28 days after a single intraperitoneal administration of the chemical. The changes in gene expression at 4 h were the most remarkable. We examined ethanol as a nongenotoxic non-hepatocarcinogen because it is not a bacterial or mammalian cell mutagen, is generally negative in in vivo genotoxicity tests (44) , and has not generated distinct carcinogenicity data in rodent liver cancer, although there is some inadequate evidence for the carcinogenicity of ethanol and alcoholic beverages in experimental animals (45) .
DiŠerential gene expression proˆling between genotoxic and non-genotoxic rat hepatocarcinogens as analyzed by qPCR and PCA: More recently, we applied our mouse candidate marker genes (9, 17, 18) to rat hepatocarcinogens in an established rat liver genotoxicity test system (46) . We evaluated the gene expression proˆles in rat liver treated with 4 chemicals [DEN, 2,6-dinitrotoluene (DNT), DEHP, and phenacetin (PNT)] that were previously examined using the liver micronucleus assay by the CSGMT/JEMS･MMS collaborative study group (47, 48) . qPCR analysis of 33 genes was conducted on liver samples from groups of 4 male 4-week-old F344 rats at 4 and 48 h after a single oral administration of chemicals [2 genotoxic hepatocarcinogens, DEN (12.5, 25 and 50 mg/kg bw) and DNT (125 and 250 mg/kg bw); a nongenotoxic hepatocarcinogen, DEHP (1,000 and 2,000 mg/kg bw); and a non-genotoxic non-hepatocarcinogen, PNT (500 and 1,000 mg/kg bw)]. All 32 genes, with the exception of Gapdh, exhibited statistically signiˆcant changes in gene expression as calculated using Williams' test (at least once), at 4 h and/or 48 h. Changes in gene expression were generally greater at 4 h than at 48 h. Furthermore, at 4 h, a statistically signiˆcant diŠerence was observed by Dunnett's test between genotoxic hepatocarcinogens (DEN and DNT) Fig. 3 . PCA of the gene expression levels between rat genotoxic hepatocarcinogens (DEN and DNT) and the non-genotoxic hepatocarcinogen (DEHP) and additionally the non-genotoxic non-hepatocarcinogen (PNT) as quantiˆed by qPCR. The mean values of triplicate qPCR assays for each sample were statistically analyzed using PCA program in GeneSpringGX11.0.1. Results of PCA are shown in the two-or three-dimensional contribution scores for component numbers 1, 2 and 3 (PC1, PC2 and PC3). The contribution scores were produced by conversion from each eigenvector value. A: 4 h with 16 genes (Ccnf, Ccng1, Cyp4a1, Ddit4l, Egfr, Gadd45g, Gdf15, Hspb1, Ighbp1, Jun, Myc, Net1, Phlda3, Pml, Rcan1 and Tubb2c), B: 48 h with 10 genes (Aen, Ccng1, Cdkn1a, Cyp21a1, Cyp4a1, Gdf15, Igfbp1, Mdm2, Phlda3 and Pmm1). Genotoxic hepatocarcinogens (•, DEN-L: DEN low dose, DEN-M: DEN middle dose, DEN-H: DEN high dose, DNT-L: DNT low dose and DENT-H: DNT high dose), a non-genotoxic hepatocarcinogen (○, DEHP-L: DEHP low dose and DEHP-H: DEHP high dose) and a non-genotoxic nonhepatocarcinogen (•, PNT-L: PNT low dose and PNT-H: PNT high dose). PCA successfully diŠerentiated the genotoxic hepatocarcinogen (in ---circle) from the non-genotoxic hepatocarcinogen (in … circle) and non-genotoxic non-hepatocarcinogen (in ---circle) with principal component 1 at 4 and 48 h (Fig. 3A-1 and Fig. 3B-1 ). The hepatocarcinogens (in ---circle) were distinguished from the non-hepatocarcinogen (in ---circle) with PC1, PC2 and PC3 at 4 and 48 h (Fig. 3A-2 and 3B-2). (46) and the non-genotoxic hepatocarcinogen (DEHP) in 19 genes (Aen, Btg2, Ccnf, Ccng1, Ddit4l, Gadd45g, Gdf15, Hspb1, Jun, Lpp, Myc, Net1, Phlda3, Plk2, Pml, Pmm1, Rcan1, Tnf, and Tubb2c) and between genotoxic hepatocarcinogens and the non-genotoxic non-hepatocarcinogen (PNT) in 18 genes (Aen, Bax, Ccnf, Ccng1, Ddit4l, Ephx1, Gdf15, Hspb1, Jun, Myc, Net1, Phlda3, Plk2, Pml, Pmm1, Rcan1, Tnf, and Tubb2c)
At 4 h, DEN and DNT produced a distinct dosedependent increase in 10 genes (Aen, Btg2, Ccng1, Cdkn1a, Ddit4l, Gdf15, Jun, Phlda3, Rcan1, and Tubb2c), with the exception of Aen under DNT. At 48 h, DEN and DNT produced dose-dependent increases in Ccng1, Cdkn1a, and Phlda3. However, DEHP and PNT did not necessarily cause dose-dependent increases in these 10 genes at 4 and 48 h. Furthermore, a statistically signiˆcant diŠerence was observed using Dunnett's test between genotoxic hepatocarcinogens and one nongenotoxic hepatocarcinogen (DEHP) and/or the nongenotoxic non-hepatocarcinogen (PNT) for 9 of the genes, with the exception of Cdkn1a at 4 h and Aen, Ccng1, Cdkn1a, Gdf15, Phlda3, and Tubb2c at 48 h.
Statistical analysis using PCA clearly diŠerentiated the gene expression proˆles between the genotoxic hepatocarcinogens and the non-genotoxic hepatocarcinogen and/or the non-genotoxic non-hepatocarcinogen. The PCA of all 32 genes were able to diŠerentiate genotoxic hepatocarcinogens from the non-genotoxic hepatocarcinogen and/or the non-genotoxic nonhepatocarcinogen at 4 and 48 h. Furthermore, we selected speciˆc genes to obtain an optimal separation between genotoxic hepatocarcinogens and the nongenotoxic hepatocarcinogen and/or the non-genotoxic non-hepatocarcinogen using PCA. PCA on 16 genes (Ccnf, Ccng1, Cyp4a1, Ddit4l, Egfr, Gadd45g, Gdf15, Hspb1, Ighbp1, Jun, Myc, Net1, Phlda3, Pml, Rcan1, and Tubb2c) at 4 h and on 10 genes (Aen, Ccng1, Cdkn1a, Cyp21a1, Cyp4a1, Gdf15, Igfbp1, Mdm2, Phlda3, and Pmm1) at 48 h optimally diŠerentiated the genotoxic hepatocarcinogens from the non-genotoxic hepatocarcinogen as well as the non-genotoxic nonhepatocarcinogen with principal component 1 (PC1) (Fig. 3A-1 at 4 h and Fig. 3B-1 at 48 h) . The hepatocarcinogens were distinguished from the non-hepatocarcinogen (PNT) with PC1, PC2, and PC3 in 3 dimensions at 4 and 48 h (Fig. 3A-2 and 3B-2) (46) .
Eight major biological processes similar to mouse hepatocarcinogens were extracted by gene ontology analysis: apoptosis, the cell cycle, cell proliferation, DNA damage, DNA repair, oxidative stress, oncogenesis, and tumor suppression. The major, biologically relevant gene pathway suggested was the DNA damage response pathway, resulting from a Tp53-mediated signaling pathway leading to the induction of apoptosis.
Changes in the expression of Cdkn1a and Hmox1 proteins as determined by immunohistochemical analyses, namely, the level of apoptosis as measured by the TUNEL assay and histology, were observed in the genotoxic hepatocarcinogen-treated rats at 48 h but were nearly undetectable at 4 h in all groups. The immunohistochemical results generally agreed with the results of the gene expression analyses for these proteins and with apoptotic gene expression at 48 h.
The present results showed that mouse candidate marker genes are applicable for diŠerentiating genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens examined in rat liver. These results were also consistent with the results of micronucleus assays in young rats (47, 48) .
Regarding additional explanations, DEN and DNT exhibited positive results (48) and DEHP (47) and PNT (48) exhibited negative results in the liver micronucleus assay. DEN (49) and DEHP (50) induce hepatocellular carcinoma in mice and rats. DNT induces hepatocellular carcinoma in rats but not in mice (51) . Whether the mouse candidate marker genes will also be responsive to DNT in rat liver is a topic of interest. The present results show that our mouse candidate marker genes were also useful for discriminating DNT from the non-genotoxic hepatocarcinogen in young rat liver. PNT has been shown to induce tumors of the urinary tract in mice and rats and tumors of the nasal cavity in rats (52). The induction of liver tumors in mice and rats by PNT has not previously been reported, although the addition of Nhydroxyphenacetin, a PNT metabolite, has been shown to induce liver tumors in rats (53) . DEN (49) and DNT (51) are positive and DEHP (50) and PNT (54) are negative by the Ames test using a rat S9 mix.
Attempts at Organ-speciˆc In Vivo Short-term Assays for the Potential Tumor-Initiating and -Promoting Activities of Chemicals in the Glandular Stomach of Fischer Rats
Cancers of the stomach are the second leading causes of human cancer mortality in the world; however, only a few glandular stomach carcinogens have been identied in experimental animal carcinogenesis (55) . Prior to 1999, stomach cancer was the major cause of cancerrelated death in Japan. In the 1960s, Sugimura and Fujimura successfully induced tumor production in rat glandular stomach mucosa using a mutagen, N-methyl-N?-nitro-N-nitrosoguanidine (MNNG) (56) . Organspeciˆc in vivo short-term tests for stomach carcinogens were not reported in the early 1980s. Therefore, my collaborators and I developed the potential tumor-initiating and -promoting activities of compounds in rat glandular stomach mucosa by measuring DNA damage and repair and cell proliferation to identify associated hazards. We studied potential tumor-initiating activity by measuring the induction of UDS and DSS and tumorpromoting activity by measuring the induction of RDS and ODC in the rat glandular stomach mucosa of male Fischer (F344) rats after oral administration. We reported our results on 54 compounds and summarized these results in our review (57, 58) .
UDS and RDS are commonly measured by autoradiography, but we measured them using a liquid scintillation counter. We believed that using a liquid scintillation counter would eliminate the subjective counting of [ 3 H]dThd incorporation into cells (59) . Initially, we compared these two approaches by quantifying the DNA synthesis in the pyloric mucosa of individual rats in the presence and absence of hydroxyurea (HU, an inhibitor of RDS) simultaneously. We conˆrmed that the liquid scintillation counter method was useful in examining UDS and RDS in rat glandular stomach mucosa (Fig. 4 and Table 1) (60) .
As stomach cancer is often induced in the pyloric mucosa of the glandular stomach mucosa in humans and rodents, we mainly studied the pyloric mucosa. The glandular stomach mucosa is composed of fundic mucosa and pyloric mucosa. The pyrolic mucosa is in turn mainly composed of surface mucous cells and pyloric gland cells. The fundic mucosa is mainly composed of surface mucous cells, chief cells, parietal cells, and mucous neck cells.
Results of UDS in rat glandular stomach: Four types of responses were observed after the oral administration of compounds (61) . Type 1: the induction of UDS but not the stimulation of RDS was observed at 1-2 h and strong enhancement of RDS was observed at 16 h (demonstrated by 4-nitroquinoline 1-oxide (4NQO), a genotoxic glandular stomach carcinogen). Type 2: the induction of UDS and some stimulation of MNNG (60,61), 1-methyl-1-nitrosourea (MNU) (62) , N-nitroso-N-methylurethane (NMUT) (60), 4NQO (60, 61) , and N-propyl-N?-nitro-N-nitrosoguanidine (PNNG) (60) ] all induced UDS dose-dependently 2 h after administration (57) . In contrast, 5 liver carcinogens [2AAF (60) (59), and broiledˆsh extract (59)], hickory smoke condensate without NaNO2 (66) , and glycocholate (72) showed negative results.
We tested 30 compounds using the UDS method. Eight compounds were positive, including 6 genotoxic glandular stomach carcinogens; 16 compounds were negative, including 5 liver carcinogens, a lung and kidney carcinogen, a forestomach carcinogen, a glandular stomach tumor promoter, and 2 non-genotoxic glandular stomach carcinogens; and 6 compounds were equivocal. The organ speciˆcity of UDS induction in the glandular stomach, forestomach, colon, liver, and epidermis was high as shown in Table 2 (partly in 57).
Results of DSS in rat glandular stomach: Figure 5 shows the elution patterns of DNA from aˆlter. MNNG, a glandular stomach carcinogen, at doses of 1-100 mg/kg body weight, induced DSS dose-dependently 2 h after oral administration (73) . The elution rate constant was calculated from the slope of the elution curve. Figure 5 shows the time dependency of DSS induction, with repair expressed as an elution rate constant with MNNG at a dose of 10 mg/kg body weight. The induction of DSS was maximal 2 h after oral administration of MNNG (61) and 4NQO (61) .
Six genotoxic glandular stomach carcinogens [ENNG (74) , MNNG (73) , MNU (62), NMUT (74) , 4NQO (74) , and PNNG (74)] all showed dose-dependent induction of DSS 2 h after administration (57) . In contrast, 2 liver (74) showed negative results. Omeprazole showed an equivocal result (74) . We examined 20 compounds by the DSS assay. Twelve compounds were positive, including 6 genotoxic glandular stomach carcinogens, 7 compounds were negative, including 2 liver carcinogens, 2 non-genotoxic glandular stomach carcinogens, and 1 glandular stomach tumor promoter and 1 compound was equivocal.
Results of RDS in the Rat Glandular Stomach: Figure 6 shows the time-dependency of the increase in RDS induced by the glandular stomach carcinogen MNNG and glandular stomach tumor promoter NaCl as determined by both the liquid scintillation counter method and autoradiography (78 (59) showed positive results. OiV (77) and methylhydroquinone (64) showed equivocal results. We examined 32 compounds by the RDS method. We obtained 26 positive results, including 6 genotoxic glandular stomach carcinogens, 2 non-genotoxic glandular stomach carcinogens, and 5 glandular stomach tumor promoters; 4 negative results, including 3 liver carcinogens; and 2 equivocal results.
Results of ODC in the rat glandular stomach: ODC activity catalyzes the production of putrescine in theˆrst rate-limiting step of polyamine biosynthesis. The diamine putrescine and the polyamines spermidine and spermine are cationic molecules found in all eukaryotic cells. Polyamine content is tightly regulated through biosynthesis, catabolism, uptake, and eOEux mechanisms to maintain optimal levels that are required for cellular events such as DNA replication, gene transcription, mRNA translation and ion channel function. Excess polyamine accumulation is linked to neoplastic growth (82) . We assayed ODC activity as a measure of potential tumor promoting activity.
The time-dependency of ODC activity induction in the pyloric mucosa by taurocholate, NaCl, catechol, K2S2O5, formaldehyde and glyoxal was transient and reached a maximum after 4 h by taurocholate (72), 6-9 h by NaCl (78) and catechol (63) , and 16 h by glyoxal (68) , formaldehyde (80) and K2S2O5 (81) . ODC activity returned to the control level within 48 h after administration of these compounds (57) .
Six (71) showed dose-dependent induction of ODC activity in rat stomach pyloric mucosa after oral administration (57) . Methylhydroquinone showed an equivocal result (64) . MgSO4 saccharose (81) , taurolithocholate (72) , and OiV fraction (77) showed negative results (57) .
We examined 45 compounds by the ODC method. We observed 37 positive results, including 6 genotoxic glandular stomach carcinogens, 2 non-genotoxic glandular stomach carcinogens, and 5 glandular stomach tumor promoters; 7 negative results, including 3 liver carcinogens; and 1 equivocal result.
Predictions regarding Glyoxal and NIAN: In our test, glyoxal induced DSS, RDS, and ODC in rat stomach pyloric mucosa (73) . Induction of UDS by glyoxal was equivocal (73) . Glyoxal is a mutagenic dicarbonyl compound found in heated foods (83) . Later, it was reported that glyoxal promoted the incidence of adenocarcinomas in rat stomach pyloric mucosa pretreated with MNNG and NaCl (84) .
Additionally, our analysis demonstrated that NIAN induced DSS, RDS, and ODC in rat stomach pyloric mucosa (70) . Induction of UDS by NIAN was equivocal (70) . The precursor of NIAN, indole-3-acetonitrile, was present in Chinese cabbage (85) . It was recently reported that NIAN induced glandular stomach cancers in Helicobacter pylori-infected Mongolian gerbils (86) .
In Vivo Short-term Tests in the Rat liver, Forestomach, Colon and in the Hairless Mouse Epidermis as Determined by UDS and RDS Using a Liquid Scintillation Counter
We studied the UDS and RDS methods in the rat liver (10) (11) (12) . We quantiˆed DNA synthesis in hepatocytes isolated from liver after chemical administration in the presence and absence of HU, an inhibitor of RDS, simultaneously. We compared autoradiography method and the liquid scintillation counter method and conrmed that liquid scintillation counter method was useful in examining UDS and RDS in the rat liver (12, 87) . Two genotoxic liver carcinogens, 2AAF and DMN, showed induction of UDS dose-dependently 2 h after administration (10) . However, the non-genotoxic hepatocarcinogen CCl4 showed a negative result in the induction of UDS but a positive result in the induction of RDS (12) .
We studied the UDS method in the rat forestomach and colon. Three forestomach carcinogens, MNNG, MNU, and NMUT induced UDS in forestomach stratied squamous epithelium but forestomach carcinogen benzo[a]pyrene showed an equivocal result and non-carcinogens 4-acetylamino‰uorene and pyrene exhibited a negative result (58, 88) . Three colon carcinogens, MNNG, MNU, and methylazoxymethanol acetate, induced UDS in colon mucosa but non-colon carcinogens 4NQO and 2AAF did not (58) .
We studied the UDS method in the hairless mouse epidermis (89) (90) (91) (92) . Five genotoxic skin carcinogens, benzo[a]pyrene, diepoxybutane, 7,12-dimethylbenzo[a]pyrene, MNNG, and 4NQO showed induction of UDS dose-dependently 2 h after treatment and a negative control, 1,2-epoxydodecane showed negative UDS (89) . UDS was induced in hairless mouse epidermis by ultraviolet light (90, 91) as well as by 8-methoxypsoralen plus ultraviolet A (92).
Chromosomal Aberrations, Micronuclei, and Sister-chromatid Exchanges in the Rat Liver Chromosomal aberrations, micronuclei, and sisterchromatid exchanges were induced in rat liver with genotoxic hepatocarcinogens 2AAF and DMN but not with a non-genotoxic hepatocarcinogen CCl4 (93, 94) . Heterocyclic amines [Trp-P-1, Trp-P-2, Glu-P-1, Glu-P-2, IQ, nitro-IQ, and MeIQx] induced chromosomal aberrations and sister-chromatid exchanges (94) . We 
Conclusion
The prediction of carcinogenicity of environmental chemicals is essential for human health. Five decades of experimental animal carcinogenicity studies, 4 decades of short-term test studies for mutagens and carcinogens, and recent progress in statistical analysis have not yet yielded ideal methods for the prediction of human cancer hazards and risks. We are still in the incomplete stages of such a development. I have attempted to develop various organ-speciˆc in vivo short-term tests, mainly in the liver and stomach (Table 3) .
During the past decade, our study group Toxicogenomics/JEMS･MMS attempted to use gene expression proˆling in the rodent liver for in vivo shortterm tests to identify mutagens and carcinogens to study the mode of action of particular chemicals. We successfully discriminated genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens in the mouse and rat liver by statistical analysis using PCA based on gene expression proˆles as determined by qPCR. I expect that toxicogenomics methods would promote the investigation of the mode of action of particular chemicals for carcinogenicity in future. At present Comet assay (95) , UDS (87) and micronucleus tests (47, 48) are often used for in vivo short-term liver tests and are rather simple procedures; however, they simply detect DNA damage but not reveal the mode of action of particular chemicals.
Previously, our group developed UDS, RDS, DSS, and ODC, mainly in the glandular stomach and additionally in rat forestomach, colon, and liver and hairless mouse epidermis, to identify any associated hazards. The organ-speciˆcity of our methods is high as shown in Table 2 . Although we examined 62 compounds in the glandular stomach, this number may still not be su‹cient for statistical validation. Cancers of the stomach are the second leading cause of human cancer mortality; however, only a few glandular stomach carcinogens have been identiˆed in experimental animal carcinogenesis (55) . Helicobacter pylori (H. pylori) is thought to be one of the most important factors for human stomach disorders, including neoplasia and a new animal model using H. pylori-infected Mongolian gerbils has been proposed (96) . Only few organ-speciˆc in vivo short-term test methods for glandular stomach are available including transgenic rodent assay; only results of MNNG (97, 98) and MNU (98) were reported and are consistent with our results. Rarely was 32 P-postlabeling analysis applied in the glandular stomach mucosa (99) . Recently in vivo Comet assay has become increasingly used in in vivo short-term test (95) . However, the organspeciˆcity of the Comet assay, at least in the glandular stomach mucosa, is not necessarily high, and the method did not necessarily discriminate the glandular stomach from forestomach (100). 
